Chat with us, powered by LiveChat

Loading...

Esoteric Testing Market Report

RA00584

Esoteric Testing Market, by Technology (Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Mass Spectrometry, Real Time – PCR, Flow Cytometry, Radioimmunoassay, Others), Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Immunology Testing, Genetic Testing, Toxicology Testing, Neurology Testing, Others), Laboratory Type (Independent & Reference Laboratories, Hospital Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA00584

Pages: 185

Jan 2023

The global esoteric testing market is estimated to surpass $46,392.8 million by 2027, exhibiting a CAGR of 9.8% from 2020 to 2027.

OFFERINGS OF THE REPORT:

The report offers comprehensive analysis of the global esoteric testing market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market.

The report also sheds light on present scenario and upcoming trends and developments that are contributing in the growth of the market. In addition, key market boomers and opportunities driving the market growth are provided in the report. Besides, restraints and challenges that hold power to obstruct the market growth are also profiled in the report. The report also offers Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.

Based on the key forces molding the market, the report offers future perspective and growth outlook of the global market. The report offers market size and forecast by keenly evaluating every segment of the global esoteric testing market. Regional market breakdown of these segments is also offered in the report. The report divides the global esoteric testing market into four main regions including Europe, North America, Asia-Pacific, and LAMEA. Furthermore, these regions are sub-divided to profile detailed panorama of the esoteric testing market across major countries in specific regions. Moreover, the report reveals some of the recent developments, trends, and forthcoming opportunities in every region.

HIGHLIGHTS OF THE MARKET

  • The report offers market size and forecast for the period from 2019 to 2027
  • This report highlights trends, innovations, and new developments along with a detailed quantitative analysis of the esoteric testing market during the period of forecast
  • The prevailing and upcoming opportunities along with the tactical assessment of the global esoteric testing market growth is provided
  • The market size and estimations are based on a comprehensive analysis of market drivers and restraints and key innovations in the esoteric testing market
  • Information on leading market players, Porter’s Five Analysis, and top winning business strategies is offered
  • The development plans and initiatives undertaken by the top market players are highlighted to understand the competitive landscape of the market

KEY MARKET SEGMENTS

The report segments the global market into technology ,type ,laboratory type

  • Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Mass Spectrometry, Real Time
  • 1. RESEARCH METHODOLOGY

    • 1.1. Desk Research

    • 1.2. Real time insights and validation

    • 1.3. Forecast model

    • 1.4. Assumptions and forecast parameters

    • 1.5. Market size estimation

      • 1.5.1. Top-down approach

      • 1.5.2. Bottom-up approach

  • 2. REPORT SCOPE

    • 2.1. Market definition

    • 2.2. Key objectives of the study

    • 2.3. Report overview

    • 2.4. Market segmentation

    • 2.5. Overview of the impact of COVID-19 on Global Esoteric Testing Market

  • 3. EXECUTIVE SUMMARY

  • 4. MARKET OVERVIEW

    • 4.1. Introduction

    • 4.2. Growth impact forces

      • 4.2.1. Drivers

      • 4.2.2. Restraints

      • 4.2.3. Opportunities

    • 4.3. Market value chain analysis

      • 4.3.1. List of raw material suppliers

      • 4.3.2. List of manufacturers

      • 4.3.3. List of distributors

    • 4.4. Innovation & sustainability matrices

      • 4.4.1. Technology matrix

      • 4.4.2. Regulatory matrix

    • 4.5. Porter’s five forces analysis

      • 4.5.1. Bargaining power of suppliers

      • 4.5.2. Bargaining power of consumers

      • 4.5.3. Threat of substitutes

      • 4.5.4. Threat of new entrants

      • 4.5.5. Competitive rivalry intensity

    • 4.6. PESTLE analysis

      • 4.6.1. Political

      • 4.6.2. Economical

      • 4.6.3. Social

      • 4.6.4. Technological

      • 4.6.5. Environmental

    • 4.7. Impact of COVID-19 on Esoteric Testing Market

      • 4.7.1. Pre-covid market scenario

      • 4.7.2. Post-covid market scenario

  • 5. Esoteric Testing Market, By Technology

    • 5.1. Overview

    • 5.2 Chemiluminescence Immunoassay (CLIA)

      • 5.2.1 Definition, key trends, growth factors, and opportunities

      • 5.2.2 Market size analysis, by region, 2020-2027

      • 5.2.3 Market share analysis, by country, 2020-2027

    • 5.3 Enzyme-linked Immunosorbent Assay (ELISA)

      • 5.3.1 Definition, key trends, growth factors, and opportunities

      • 5.3.2 Market size analysis, by region, 2020-2027

      • 5.3.3 Market share analysis, by country, 2020-2027

    • 5.4 Mass Spectrometry

      • 5.4.1 Definition, key trends, growth factors, and opportunities

      • 5.4.2 Market size analysis, by region, 2020-2027

      • 5.4.3 Market share analysis, by country, 2020-2027

    • 5.5 Real Time – PCR

      • 5.5.1 Definition, key trends, growth factors, and opportunities

      • 5.5.2 Market size analysis, by region, 2020-2027

      • 5.5.3 Market share analysis, by country, 2020-2027

    • 5.6 Flow Cytometry

      • 5.6.1 Definition, key trends, growth factors, and opportunities

      • 5.6.2 Market size analysis, by region, 2020-2027

      • 5.6.3 Market share analysis, by country, 2020-2027

    • 5.7 Radioimmunoassay

      • 5.7.1 Definition, key trends, growth factors, and opportunities

      • 5.7.2 Market size analysis, by region, 2020-2027

      • 5.7.3 Market share analysis, by country, 2020-2027

    • 5.8 Others

      • 5.8.1 Definition, key trends, growth factors, and opportunities

      • 5.8.2 Market size analysis, by region, 2020-2027

      • 5.8.3 Market share analysis, by country, 2020-2027

    • 5.9 Research Dive Exclusive Insights

      • 5.9.1 Market attractiveness

      • 5.9.2 Competition heatmap

  • 6. Esoteric Testing Market, By Type

    • 6.1. Overview

    • 6.2 Infectious Diseases Testing

      • 6.2.1 Definition, key trends, growth factors, and opportunities

      • 6.2.2 Market size analysis, by region, 2020-2027

      • 6.2.3 Market share analysis, by country, 2020-2027

    • 6.3 Endocrinology Testing

      • 6.3.1 Definition, key trends, growth factors, and opportunities

      • 6.3.2 Market size analysis, by region, 2020-2027

      • 6.3.3 Market share analysis, by country, 2020-2027

    • 6.4 Oncology Testing

      • 6.4.1 Definition, key trends, growth factors, and opportunities

      • 6.4.2 Market size analysis, by region, 2020-2027

      • 6.4.3 Market share analysis, by country, 2020-2027

    • 6.5 Immunology Testing

      • 6.5.1 Definition, key trends, growth factors, and opportunities

      • 6.5.2 Market size analysis, by region, 2020-2027

      • 6.5.3 Market share analysis, by country, 2020-2027

    • 6.6 Genetic Testing

      • 6.6.1 Definition, key trends, growth factors, and opportunities

      • 6.6.2 Market size analysis, by region, 2020-2027

      • 6.6.3 Market share analysis, by country, 2020-2027

    • 6.7 Toxicology Testing

      • 6.7.1 Definition, key trends, growth factors, and opportunities

      • 6.7.2 Market size analysis, by region, 2020-2027

      • 6.7.3 Market share analysis, by country, 2020-2027

    • 6.8 Neurology Testing

      • 6.8.1 Definition, key trends, growth factors, and opportunities

      • 6.8.2 Market size analysis, by region, 2020-2027

      • 6.8.3 Market share analysis, by country, 2020-2027

    • 6.9 Others

      • 6.9.1 Definition, key trends, growth factors, and opportunities

      • 6.9.2 Market size analysis, by region, 2020-2027

      • 6.9.3 Market share analysis, by country, 2020-2027

    • 6.10 Research Dive Exclusive Insights

      • 6.10.1 Market attractiveness

      • 6.10.2 Competition heatmap

  • 7. Esoteric Testing Market, By Laboratory Type

    • 7.1. Overview

    • 7.2 Independent & Reference Laboratories

      • 7.2.1 Definition, key trends, growth factors, and opportunities

      • 7.2.2 Market size analysis, by region, 2020-2027

      • 7.2.3 Market share analysis, by country, 2020-2027

    • 7.3 Hospital Laboratories

      • 7.3.1 Definition, key trends, growth factors, and opportunities

      • 7.3.2 Market size analysis, by region, 2020-2027

      • 7.3.3 Market share analysis, by country, 2020-2027

    • 7.4 Research Dive Exclusive Insights

      • 7.4.1 Market attractiveness

      • 7.4.2 Competition heatmap

  • 8. Esoteric Testing Market, By Region

    • 8.1 North America

      • 8.1.1 U.S

        • 8.1.1.1 Market size analysis, By Technology, 2020-2027

        • 8.1.1.2 Market size analysis, By Type, 2020-2027

        • 8.1.1.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.1.2 Canada

        • 8.1.2.1 Market size analysis, By Technology, 2020-2027

        • 8.1.2.2 Market size analysis, By Type, 2020-2027

        • 8.1.2.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.1.3 Mexico

        • 8.1.3.1 Market size analysis, By Technology, 2020-2027

        • 8.1.3.2 Market size analysis, By Type, 2020-2027

        • 8.1.3.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.1.4 Research Dive Exclusive Insights

        • 8.1.4.1 Market attractiveness

        • 8.1.4.2 Competition heatmap

    • 8.2 Europe

      • 8.2.1 Germany

        • 8.2.1.1 Market size analysis, By Technology, 2020-2027

        • 8.2.1.2 Market size analysis, By Type, 2020-2027

        • 8.2.1.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.2.2 UK

        • 8.2.2.1 Market size analysis, By Technology, 2020-2027

        • 8.2.2.2 Market size analysis, By Type, 2020-2027

        • 8.2.2.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.2.3 France

        • 8.2.3.1 Market size analysis, By Technology, 2020-2027

        • 8.2.3.2 Market size analysis, By Type, 2020-2027

        • 8.2.3.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.2.4 Spain

        • 8.2.4.1 Market size analysis, By Technology, 2020-2027

        • 8.2.4.2 Market size analysis, By Type, 2020-2027

        • 8.2.4.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.2.5 Italy

        • 8.2.5.1 Market size analysis, By Technology, 2020-2027

        • 8.2.5.2 Market size analysis, By Type, 2020-2027

        • 8.2.5.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.2.6 Rest of Europe

        • 8.2.6.1 Market size analysis, By Technology, 2020-2027

        • 8.2.6.2 Market size analysis, By Type, 2020-2027

        • 8.2.6.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.2.7 Research Dive Exclusive Insights

        • 8.2.7.1 Market attractiveness

        • 8.2.7.2 Competition heatmap

    • 8.3 Asia-Pacific

      • 8.3.1 China

        • 8.3.1.1 Market size analysis, By Technology, 2020-2027

        • 8.3.1.2 Market size analysis, By Type, 2020-2027

        • 8.3.1.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.3.2 Japan

        • 8.3.2.1 Market size analysis, By Technology, 2020-2027

        • 8.3.2.2 Market size analysis, By Type, 2020-2027

        • 8.3.2.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.3.3 India

        • 8.3.3.1 Market size analysis, By Technology, 2020-2027

        • 8.3.3.2 Market size analysis, By Type, 2020-2027

        • 8.3.3.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.3.4 Australia

        • 8.3.4.1 Market size analysis, By Technology, 2020-2027

        • 8.3.4.2 Market size analysis, By Type, 2020-2027

        • 8.3.4.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.3.5 South Korea

        • 8.3.5.1 Market size analysis, By Technology, 2020-2027

        • 8.3.5.2 Market size analysis, By Type, 2020-2027

        • 8.3.5.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.3.6 Rest of Asia-Pacific

        • 8.3.6.1 Market size analysis, By Technology, 2020-2027

        • 8.3.6.2 Market size analysis, By Type, 2020-2027

        • 8.3.6.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.3.7 Research Dive Exclusive Insights

        • 8.3.7.1 Market attractiveness

        • 8.3.7.2 Competition heatmap

    • 8.4 LAMEA

      • 8.4.1 Brazil

        • 8.4.1.1 Market size analysis, By Technology, 2020-2027

        • 8.4.1.2 Market size analysis, By Type, 2020-2027

        • 8.4.1.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.4.2 Saudi Arabia

        • 8.4.2.1 Market size analysis, By Technology, 2020-2027

        • 8.4.2.2 Market size analysis, By Type, 2020-2027

        • 8.4.2.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.4.3 UAE

        • 8.4.3.1 Market size analysis, By Technology, 2020-2027

        • 8.4.3.2 Market size analysis, By Type, 2020-2027

        • 8.4.3.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.4.4 South Africa

        • 8.4.4.1 Market size analysis, By Technology, 2020-2027

        • 8.4.4.2 Market size analysis, By Type, 2020-2027

        • 8.4.4.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.4.5 Rest of LAMEA

        • 8.4.5.1 Market size analysis, By Technology, 2020-2027

        • 8.4.5.2 Market size analysis, By Type, 2020-2027

        • 8.4.5.3 Market size analysis, By Laboratory Type, 2020-2027

      • 8.4.6 Research Dive Exclusive Insights

        • 8.4.6.1 Market attractiveness

        • 8.4.6.2 Competition heatmap

  • 9. Competitive Landscape

    • 9.1 Top winning strategies, 2020-2027

      • 9.1.1 By strategy

      • 9.1.2 By year

    • 9.2 Strategic overview

    • 9.3 Market share analysis, 2020-2027

  • 10. Company Profiles

    • 10.1 ACM Global Laboratories

      • 10.1.1 Overview

      • 10.1.2 Business segments

      • 10.1.3 Product portfolio

      • 10.1.4 Financial performance

      • 10.1.5 Recent developments

      • 10.1.6 SWOT analysis

    • 10.2 American Esoteric Laboratories (AEL)

      • 10.2.1 Overview

      • 10.2.2 Business segments

      • 10.2.3 Product portfolio

      • 10.2.4 Financial performance

      • 10.2.5 Recent developments

      • 10.2.6 SWOT analysis

    • 10.3 Arup Laboratories

      • 10.3.1 Overview

      • 10.3.2 Business segments

      • 10.3.3 Product portfolio

      • 10.3.4 Financial performance

      • 10.3.5 Recent developments

      • 10.3.6 SWOT analysis

    • 10.4 BioMONTR

      • 10.4.1 Overview

      • 10.4.2 Business segments

      • 10.4.3 Product portfolio

      • 10.4.4 Financial performance

      • 10.4.5 Recent developments

      • 10.4.6 SWOT analysis

    • 10.5 Fulgent Genetics Inc

      • 10.5.1 Overview

      • 10.5.2 Business segments

      • 10.5.3 Product portfolio

      • 10.5.4 Financial performance

      • 10.5.5 Recent developments

      • 10.5.6 SWOT analysis

    • 10.6 Genomic Health

      • 10.6.1 Overview

      • 10.6.2 Business segments

      • 10.6.3 Product portfolio

      • 10.6.4 Financial performance

      • 10.6.5 Recent developments

      • 10.6.6 SWOT analysis

    • 10.7 Invitae

      • 10.7.1 Overview

      • 10.7.2 Business segments

      • 10.7.3 Product portfolio

      • 10.7.4 Financial performance

      • 10.7.5 Recent developments

      • 10.7.6 SWOT analysis

    • 10.8 Laboratory Corporation of America

      • 10.8.1 Overview

      • 10.8.2 Business segments

      • 10.8.3 Product portfolio

      • 10.8.4 Financial performance

      • 10.8.5 Recent developments

      • 10.8.6 SWOT analysis

    • 10.9 Mayo Medical Laboratories

      • 10.9.1 Overview

      • 10.9.2 Business segments

      • 10.9.3 Product portfolio

      • 10.9.4 Financial performance

      • 10.9.5 Recent developments

      • 10.9.6 SWOT analysis

    • 10.10 Miraca Holdings Inc

      • 10.10.1 Overview

      • 10.10.2 Business segments

      • 10.10.3 Product portfolio

      • 10.10.4 Financial performance

      • 10.10.5 Recent developments

      • 10.10.6 SWOT analysis

Purchase Options

Personalize this research

  • Triangulate with your own data
  • Request your format and definition
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed